Literature DB >> 1722381

Immunocytochemical localization of interferons in human trophoblast populations.

L Paulesu1, V Bocci, A King, Y M Loke.   

Abstract

It is known that Interferon (IFN) is present in normal body fluids and tissues during pregnancy. Using an immunohistochemical technique and a panel of monoclonal antibodies we have localized IFN-alpha, -beta and -gamma directly on formalin-fixed paraffin-embedded normal human placentae at different stages of pregnancy and in the hydatidiform mole. The results show that IFNs is mostly localized in villous syncytiotrophoblast and in extravillous interstitial-trophoblast. No reactivity was observed in villous cytotrophoblast or in cytotrophoblast cell columns. The most intense staining was observed for IFN-alpha and -beta, while IFN-gamma was rather weak. There is then a gradual diminution in IFN reactivity with increasing gestation age being almost imperceptible at term. These results suggest that IFN may deploy antiviral, immunomodulator and differentiation activities during normal human pregnancy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722381

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  3 in total

1.  Influence of TCM therapy for supplementing Pi and nourishing Shen on dendritic cell function in patients with chronic hepatitis B treated by lamivudine.

Authors:  Yong-Hua Zhang; Yi-Hui Liu
Journal:  Chin J Integr Med       Date:  2009-03-07       Impact factor: 1.978

Review 2.  Interferons and the maternal-conceptus dialog in mammals.

Authors:  R Michael Roberts; Yizhen Chen; Toshihiko Ezashi; Angela M Walker
Journal:  Semin Cell Dev Biol       Date:  2007-10-16       Impact factor: 7.727

3.  Maternal plasma and amniotic fluid chemokines screening in fetal Down syndrome.

Authors:  Piotr Laudanski; Monika Zbucka-Kretowska; Karol Charkiewicz; Slawomir Wolczynski; Daniela Wojcik; Radoslaw Charkiewicz
Journal:  Mediators Inflamm       Date:  2014-11-16       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.